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Summary. Multi-state models can be viewed as generalizations of both the standard and competing risks models for survival
data. Models for multi-state data have been the theme of many recent published works. Motivated by bone marrow transplant
data, we propose a Bayesian model using the gap times between two successive events in a path of events experienced by a
subject. Path speciﬁc frailties are introduced to capture the dependence structure of the gap times in the paths with two or
more states. Under improper prior distributions for the parameters, we establish propriety of the posterior distribution. An
eﬃcient Gibbs sampling algorithm is developed for drawing samples from the posterior distribution. An extensive simulation
study is carried out to examine the empirical performance of the proposed approach. A bone marrow transplant data set is
analyzed in detail to further demonstrate the proposed methodology.
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1. Introduction
Markov models and Markov extension models are widely used
to model multi-state data, in which the transition probabili-
ties and transition intensities are the major study focus. There
are two major time scales used for studying transition inten-
sities: the study time since the study origin and the duration
time in the current state. Based on the time scale to use,
Markov model and Markov extension models are classiﬁed
into several categories. The non-homogeneous Markov model
assumes that the upcoming transition intensity depends on
the history only via the current state and the study time.
The homogeneous Markov model (classical Markov model)
further assumes that all transition hazards are constant. The
homogeneous semi-Markov model assumes that the transi-
tion intensity, given the current state and the duration time
in the current state, is independent of the history. The non-
homogeneous semi-Markov model allows the transition inten-
sities to depend on both of the study and duration time scales.
In our article, we are going to deal with Markov and semi-
Markov models.
Models for multi-state data have been the subject of many
published works, most of which are based on frequentist
methods. Comprehensive reviews about the development and
applications are given by, for example, Commenges (1999),
Hougaard (1999), Hougaard (2000), Andersen and Keiding
(2002), Andersen and Perme (2008), Meira-Machado et al.
(2009), Zhao (2009), Andersen and Perme (2013), and ref-
erences therein. In the article by Fiocco, Putter, and van
Houwelingen (2008), a Markovian model is adopted, semi-
parametric Cox models with transition-speciﬁc covariates are
ﬁtted, and the transition probability matrix is estimated
using the Aalen–Johansen estimator (Aalen and Johansen,
1978). Fiocco et al. (2008) also consider a model in which
some of the baseline hazards are assumed to be proportional
(see also Keiding, Klein, and Horowitz, 2001). Titman and
Sharples (2010a) propose several tools for model diagnostics.
Titman and Sharples (2010b) formulate a semi-Markov model
for discrete time survival data with an extension to situations
in which observed states are subject to classiﬁcation error. Xu,
Kalbﬂeisch, and Tai (2010) present an interesting connection
between semi-competing risks models and illness-death pro-
cesses (see Section 4.1). Ferguson, Datta, and Brock (2012)
develop an R package for summary calculations (e.g., state
occupation probabilities) in a general, possibly non-Markov,
multi-state model without covariates. The semi-competing
risks models proposed by Zeng et al. (2012) can also be inter-
preted as multi-state models.
Under a Bayesian viewpoint, Kneib and Hennerfeind (2008)
devise a model with transition intensities speciﬁed in a multi-
plicative way, enabling the inclusion of ﬂexible nonparametric
and time-varying eﬀects. Subject speciﬁc variation not ac-
counted for by covariates is captured by transition speciﬁc
frailties. The baseline transition intensities are represented
by penalized splines. Armero et al. (2012) present a Weibull
semi-Markov model for the three states disability model (see
Section 4.1). Kim, James, and Weissbach (2012) develop a
semi-parametric regression model based on a Markov process
and a beta-Dirichlet process for the cumulative intensity func-
tions. Conlon, Taylor, and Sargent (2014) present a multi-
state Markov model with a cured fraction that jointly models
recurrence and death.
As an anonymous referee pointed out, the ﬂowgraph mod-
els discussed in Huzurbazar (2005) and Warr and Huzurbazar
(2010) represent an alternative for modeling multi-state data.
These models are based on the speciﬁcation of the moment
generating function or the complex Laplace transform for the
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waiting times between two states. Up to the best of our knowl-
edge, ﬂowgraph models including frailties have not yet been
investigated.
Several important issues remain unaddressed in the existing
literature. First, the dependence structure of the gap times be-
tween two states is not always explicitly accounted for. In this
article, we take a diﬀerent approach to model multi-state data
by developing Bayesian gap time models with path speciﬁc
frailties. An anonymous referee pointed out that the frailty
represents the vulnerability of a subject. From a clinical point
of view, patients going to diﬀerent paths shall have diﬀer-
ent vulnerabilities. As discussed in Zhang et al. (2014), the
marginal distributions of the gap times after integrating out
the frailty belong to the class of generalized odds-rate hazards
(GORH) models (Banerjee et al., 2007). As the GORH model
is a non-proportional hazards model, the proposed path spe-
ciﬁc frailty model is more robust to the proportional hazards
assumption than the classical Markov and semi-Markov mod-
els in which the proportional hazards models are assumed
for the gap times. Second, within the Bayesian framework,
we characterize the conditions for posterior propriety under
improper noninformative priors speciﬁed for regression coef-
ﬁcients as well as other model parameters. Third, the path
probabilities are diﬃcult to compute under most of the ex-
isting models in the literature. However, under the proposed
path speciﬁc frailty model, the path probabilities are easily
estimated as a by-product of the Gibbs sampler. Fourth, as
stressed by Zhang et al. (2014), the computation is diﬃcult to
carry out when ﬁtting a frailty model with unknown param-
eters in the frailty distribution since the estimates of these
unknown parameters are generally unstable. The computa-
tion becomes even more challenging for ﬁtting the complex
multi-state survival data. In this regard, we develop an eﬃ-
cient Gibbs sampling algorithm via the introduction of latent
variables and reparameterizations. In addition, in the pro-
posed Bayesian approach, the derivation of the closed form
expression of the likelihood after integrating out latent frail-
ties facilitates the development of model comparison criteria
such as the deviance information criterion (DIC) and the log-
arithm of the pseudo marginal likelihood (LPML). Our simu-
lation study in Section 6 shows that these versions of DIC and
LPML yield a good statistical power to select the true model.
The rest of the article is organized as follows. Section 2
presents a detailed description of the bone marrow transplant
(BMT) data. The building blocks of the model are described
in Section 3 and some model properties are examined in Sec-
tion 4. The prior distribution is speciﬁed and the propriety
of the posterior distribution is established in Section 5. More-
over, model comparison criteria are also presented. The per-
formance of the proposed methodology is assessed through a
simulation study conducted in Section 6. In Section 7, the
methodology is applied to the analysis of the bone marrow
transplant data set presented in Section 2. Some general con-
cluding remarks are given in Section 8.
2. Bone Marrow Transplant Data
According to Fiocco et al. (2008), bone marrow transplanta-
tion is an eﬀective and standard treatment for acute leukemia,
but the procedure is associated with considerable morbidity
Figure 1. Path diagram of the BMT data.
and mortality. The BMT data used in this article are available
in the mstate package in R (de Wreede, Fiocco, and Putter,
2011). Six states are considered. As shown in Figure 1, af-
ter transplant, the patients may experience platelet recovery
(PR), acute graft-versus-host disease (AGvHD) or both PR
and AGvHD, all of which are considered as nonterminating
events. The patients may also experience either relapse or
death in remission, both of which are considered as terminat-
ing events. Graft-versus-host disease (GvHD), either acute or
chronic, is the most common non-relapse complication. Pa-
tients who develop acute GvHD are more likely to develop
chronic GvHD than others. Overall, there are 12 transitions
and the number of patients in these transitions are shown
in Figure 1. These data motivate our proposed methodology.
The data are comprised of 2279 patients treated between 1985
and 1998. Table S2 (in the Online Supplementary Materials)
presents the baseline prognostic factors.
We can also view Figure 1 as a path diagram, with boxes
representing states and arrows representing transitions from
a parent state to a child state. In Figure 1, there are K = 10
possible complete paths and their corresponding states and
transitions are given as follows: P1: 1 → 5, P2: 1 → 2 → 5,
P3: 1 → 2 → 6, P4: 1 → 2 → 4 → 5, P5: 1 → 2 → 4 → 6,
P6: 1 → 3 → 4 → 5, P7: 1 → 3 → 4 → 6, P8: 1 → 3 → 5, P9:
1 → 3 → 6, and P10: 1 → 6. There are ﬁve possible incom-
plete paths as well, including IP1: 1, IP2: 1 → 2, IP3: 1 → 3,
IP4: 1 → 2 → 4, and IP5: 1 → 3 → 4.
Among the 2279 patients who underwent transplant, the
numbers of patients belonging to these paths are 95 patients
for P1, 112 patients for P2, 39 patients for P3, 33 patients
for P4, 60 patients for P5, 74 patients for P6, 77 patients for
P7, 56 patients for P8, 197 patients for P9, 160 patients for
P10, 332 patients for IP1, 407 patients for IP2, 221 patients
for IP3, 134 patients for IP4, and 282 patients for IP5. The
median gap times in years of the transitions in Figure 1 are
0.066 for 1 → 2, 0.045 for 1 → 3, 0.627 for 1 → 5, 0.144 for
1 → 6, 0.027 for 2 → 4, 0.586 for 2 → 5, 0.479 for 2 → 6, 0.041
for 3 → 4, 0.675 for 3 → 5, 0.205 for 3 → 6, 0.578 for 4 → 5,
and 0.444 for 4 → 6.
3. Proposed Models
In this section, we introduce the two main components of our
models. We begin with some deﬁnitions. If a state does not
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have any child states, then it is an absorbing state, whereas
if a state does not have a parent state, then it is a starting
state. In the studies that we consider, there is one starting
state and one or more absorbing states. We only consider the
situation in which all the transitions are in one direction from
an early state to a late state but not vice versa. If a state is
neither a starting state nor an absorbing state, then it is a
transient state. A transient state must have both parent and
child states. As in Section 2, a sequence of connected states
from the starting state to an absorbing state is called a path.
There are J ≥ 2 states and K ≥ 1 paths. We assume that each
subject goes through just one path.
3.1. Model for Immediate Child States
For each parent state j, let Pj = {l : state l is an immediate
child state of state j} denote the collection of all possible im-
mediate child states of state j, j = 1, . . . , J . Under our setting,
the states are numbered so that we always have l > j when
l ∈ Pj. Let δj denote a possible value of a child state for the
parent state j, independent of the gap times. We assume a
multinomial logistic regression model for δj as follows:
P(δj = l|z1,α(j)) = exp(z′1α(j)l )/
∑
l∗∈Pj
exp(z′1α
(j)
l∗ ), (1)
where z1 is a p × 1 vector of covariates, α(j)l∗ is a p × 1 vector of
parent and child speciﬁc regression coeﬃcients for l∗ ∈ Pj, and
α(j) = ((α(j)l )′ : l ∈ Pj)′. To ensure identiﬁability, we assume
α
(j)
lj
= 0, where lj = max{l : l ∈ Pj}.
3.2. Models for the Gap Times with Path Speciﬁc Frailty
Let Tjl denote the gap time between two connected states
j and l. In Figure 1, we have a total of 12 gap times. Let
Sk = {l : state l is in path k} denote the collection of states
along path Pk for k = 1, . . . , K, and |Sk| denote the cardi-
nality of the set Sk. For each path Pk, in order to model
variability in the hazard not accounted for observable covari-
ates, we introduce a frailty term w, which has a path speciﬁc
distribution with parameter τk. Each subject eventually ends
up with a certain path. Each path is composed by a num-
ber of states representing intermediate points before reach-
ing a terminating state. The vulnerability, represented by the
frailty, depends on the sequence of events experienced by the
subject.
For complete paths, we assume that
w|τk ∼ gamma(1/τk, 1/τk) (2)
independently, with density function f (w|τk) =
(1/τk)
1/τkw1/τk−1 exp(−w/τk)/ (1/τk) for w > 0. The dis-
tribution of the frailty can be determined only if we know
which path the transition j → l belongs to. We emphasize
that the frailty is subject speciﬁc and the subjects undergoing
a given path have frailties that follow the same distribution.
For complete paths, it is observed that if |Sk| = 2 for the
path Pk, then the transition in Sk between two connected
states j and l cannot be shared by other paths. If |Sk| > 2,
then the transition j → l can be shared by other paths. In this
case, there will be more than one path speciﬁc conditional dis-
tributions for the corresponding gap time Tjl according to (2).
Next, given Pk, for j, l ∈ Sk, the path speciﬁc hazard func-
tion for Tjl when states j and l are connected is assumed as
hjl(t|z2,βjl,Pk) = whjl0(t) exp(z′2βjl), (3)
where the distribution of w|τk is given in (2), hjl0(·) is the
transition speciﬁc baseline hazard function, z2 is a q × 1 vec-
tor of covariates, and βjl is a vector of transition speciﬁc re-
gression coeﬃcients. In the case that δj = l, we assume that
Tjl = ∞. Notice that in the marginal model, the proportion-
ality of the hazards is relaxed, even when |Sk| = 2. For nota-
tional simplicity, we assume that the covariates z1 and z2 in
(1) and (3) are the same for all transitions. For example, for
path P4: 1 → 2 → 4 → 5, (3) implies that h12(t|z2,β12,P4) =
wh120(t) exp(z
′
2β12), h24(t|z2,β24,P4) = wh240(t) exp(z′2β24),
and h45(t|z2,β45,P4) = wh450(t) exp(z′2β45), where w|τ4 ∼
gamma(1/τ4, 1/τ4).
The baseline hazard function hjl0(·) is represented by a
piecewise constant function. First we create a partition of the
gap time axis with Mjl intervals and cutpoints 0 = cjl0 < cjl1 <
· · · < cjlMjl , where cjlMjl > tijl for all subjects i sharing the tran-
sition j → l. In this way, the intervals are (0, cjl1], (cjl1, cjl2],
. . . , (cjlMjl−1, cjlMjl ]. We also deﬁne an interval indicator Iijlm
such that Iijlm = 1 if a subject i sharing the transition j → l
failed or was right-censored in the mth interval; Iijlm = 0 oth-
erwise. In the mth interval, we assume a constant hazard λjlm,
m = 1, . . . ,Mjl, so that
hjl0(t) = λjlm and
Hjl0(t) = λjlm(t − cjl,m−1) +
m−1∑
g=1
λjlg(cjlg − cjl,g−1), (4)
when cjl,m−1 < t ≤ cjlm. In the results reported in Sections 6
and 7, for m = 1, . . . ,Mjl, we chose intervals (cjl,m−1, cjlm]
based on the percentiles of the gap times for subjects with
a complete path.
3.3. Likelihood Function
Let n denote the number of subjects. For the ith subject, let
yij denote the observed event time or right-censored time at
state j. When j = 1, which is the starting state, let yi1 = 0.
Let δij denote a possible value of child states for the parent
state j. If δij = l, then the gap time between the parent state
j and its child state l ∈ Pj can be expressed as tijl = yil − yij.
This gap time can be the gap time between two events l and
j or the gap time between a censoring time and an event
time. For a given observation i, let νi denote the indicator
of an absorbing state, with νi = 1 if an absorbing state is
reached and νi = 0 otherwise. Let Si = {si1, si2, . . . , siJi } de-
note the set of states visited by the i-th subject, comprising
a complete or incomplete path with si1 = 1, where Ji ≥ 1 is
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the number of states. We let D = (n, t, ν,S1, . . . ,Sn,Z1,Z2)
denote the observed data, where t is a vector with elements
ti,1,si2 , . . . , ti,si,Ji−1,siJi , for i = 1, . . . , n, ν = (ν1, . . . , νn)′, z1 is the
n × p matrix of covariates with the ith row z′i1, and z2 is the
n × q matrix of covariates with the ith row z′i2.
If siJi is an absorbing state, (Si) denotes the number of
the path corresponding to Si. If νi = 0, then siJi is a transient
state. In this case, let U(siJi) stand for the set of subpaths
from state siJi to every absorbing state through all the
possible transient states. Each subpath g ∈ U(siJi) has states
{si,g1, si,g2, . . . , si,gJig }, with si,g1 = siJi and such that Si ∪ g
represents a complete path. For example, in Figure 1 we see
that U(2) = {{2, 5}, {2, 6}, {2, 4, 5}, {2, 4, 6}}. For a set S∗i rep-
resenting a complete path (S∗i can be either Si or Si ∪ g), let
a(τ(S∗
i
)) =
Ji−2∏
j=1
(1 + jτ(S∗
i
)), if Ji > 2; a(τ(S∗
i
)) = 1, if Ji ≤ 2,
(5)
noticing that a(·) is obtained when we integrate
out w using the Laplace transformation of a
gamma(1/τ(S∗
i
) + Ji − 1, 1/τ(S∗
i
)) random variable. If
Si is a complete path (νi = 1), let H∗(Si) = {1 +
τ(Si)
Ji−1∑
j=1
Hsij ,si,j+1,0(ti,sij ,si,j+1) exp(z
′
i2βsij ,si,j+1)}−1/τ(Si)−Ji+1. If Si
is an incomplete path (νi = 0), the gap times are right-
censored at ti,siJi ,∗. In this case, let
H∗(Si ∪ g) =
[
1 + τ(Si∪g)
{
Ji−1∑
j=1
Hsij ,si,j+1,0(ti,sij ,si,j+1)
× exp(z′i2βsij ,si,j+1) + HsiJi ,si,g2,0(ti,siJi ,∗)
× exp(z′i2βsiJi ,si,g2)
}]−1/τ(Si∪g)−Ji+1
. (6)
The vector θ = (α′,β′,λ′, τ∗′, η)′ encapsulates all the param-
eters in our model, where τ∗ refers to the two states paths
(|S| = 2). The latent vector τ comprising all paths with |S| > 2
is included in the likelihood function to ease the computations
in Section 5.2 and Web Appendix C. Using these notations
and deﬁnitions, the likelihood function can be written as
L(θ|τ,D) =
n∏
i=1
{
a(τ(Si))H
∗(Si)
Ji−1∏
j=1
P(δi,sij = si,j+1|zi1,α(sij))hsij ,si,j+1,0(ti,sij ,si,j+1)
× exp(z′i2βsij ,si,j+1)
}I(νi=1){ Ji−1∏
j=1
P(δi,sij = si,j+1|zi1,α(sij))hsij ,si,j+1,0(ti,sij ,si,j+1)
× exp(z′i2βsij ,si,j+1)
∑
g∈U(siJi )
a(τ(Si∪g))H
∗(Si ∪ g)
Jig−1∏
j=1
P(δi,si,gj = si,g(j+1)|zi1,α(si,gj))
}I(νi=0)
. (7)
For example, for a subject i in path P2, the contribution
to the likelihood function is P(δi1 = 2|zi1,α(1))P(δi2 =
5|zi1,α(2))h120(ti12)h250(ti25) exp{z′i2(β12 + β25)}(1 + τ2)[1 +
τ2{H120(ti12) exp(z′i2β12) + H250(ti25) exp(z′i2β25)}]−1/τ2−2 (for
the remaining paths, see Web Appendix C).
4. Model Properties
4.1. A Special Case: A Three States Model
The three states model is the most simple case of our gen-
eral models, with one starting state (healthy), one transient
state (diseased), and one absorbing state (dead). The data
structure is shown in Figure S1 (in the Online Supplemen-
tary Materials) and sometimes it is also referred as a disability
model (Hougaard, 2000, Chapter 5). Under this special case,
the Markov property is examined.
Proposition 1. The three states model corresponds to a
homogeneous Markov renewal process when the baseline haz-
ard function is constant.
4.2. Path Probability
Let Pkj denote the subset of Pj such that Pkj = {l : state l is
an immediate child state of state j in path Pk}. If j is an
absorbing state, then Pkj = ∅. Based on the above models, the
path probability can be computed as
pk = pk(zc1) =
∏
j∈Sk,l∈Pkj
P(δj = l|zc1,α(j)), (8)
where zc1 denotes the ﬁxed values of some covariates upon
which we condition and Pkj = ∅. This is the probability that
a subject having characteristics zc1 will eventually end up
with path Pk. It is worthy to mention that under our model,
the path probabilities are easy to compute. These probabil-
ities can be useful for classifying subjects with a given set
of characteristics. However, these path probabilities are com-
putationally intensive under the nonparametric Markov, Cox
semi-parametric Markov, and non-Markov models. Further-
more, these clinically important probabilities have not been
examined in the literature, including, for example, Keiding
et al. (2001) and Fiocco et al. (2008), for analyzing the bone
marrow transplant data discussed in Section 2.
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4.3. Survival Probability for Terminating Events
In Figure 1, we see that relapse and death in remission are
terminating events. The relapse free probability is denoted by
P(T5 > t|zc1, zc2), with zc1 and zc2 as in (8). Following the paths
in Figure 1, we obtain
P(T5 > t|zc1, zc2) =
∫
Z01
∫
Z02
[
P(δ1 = 5|z01, zc1,α(1)){1 + τ1H150(t)ez
′
2β15}−1/τ1
+P(δ1 = 2|z01, zc1,α(1))P(δ2 = 5|z01, zc1,α(2))
∫ ∞
0
P(T12 + T25 > t|z02, zc2,β12,β25, w)
× f (w|τ2) dw + P(δ1 = 2|z01, zc1,α(1))P(δ2 = 4|z01, zc1,α(2))P(δ4 = 5|z01, zc1,α(4))
×
∫ ∞
0
P(T12 + T24 + T45 > t|z02, zc2,β12,β24,β45, w)f (w|τ4) + P(δ1 = 3|z01, zc1,α(1))
×P(δ3 = 4|z01, zc1,α(3))P(δ4 = 5|z01, zc1,α(4))
∫ ∞
0
P(T13 + T34 + T45 > t
|z02, zc2,β13,β34,β45, w)f (w|τ6)dw + P(δ1 = 3|z01, zc1,α(1))P(δ3 = 5|z01, zc1,α(3))
×
∫ ∞
0
P(T13 + T35 > t|z02, zc2,β13,β35, w)f (w|τ8) dw
]
fZ01,Z
0
2
(z01, z
0
2)dz
0
2 dz
0
1, (9)
where Z01 and Z02 denote the sample spaces of the free covari-
ates z01 and z
0
2, respectively. The detailed computations of this
probability and the survival probability P(T6 > t|zc1, zc2) are
given in Web Appendix A. Since the covariates in the BMT
data are categorical (see Table S2), integration with respect
to the covariates is performed using their joint empirical dis-
tribution. A more general nonparametric scheme is presented
in Zhang et al. (2014).
The piecewise constant hazard function in (4) facilitates
the computation of the survival probability for terminating
events. In particular, for the three and four state models in
Figures S1 and S2 (in the Online Supplementary Materials),
the survival probability has a closed form expression, which
can be derived using the results given in Web Appendix A.
Summary calculations, including state occupation and
transition probabilities, as well as state entry and exit
distributions (Ferguson et al., 2012), in models such as non-
parametric Markov, Cox semi-parametric Markov, and non-
Markov have been the subject of many studies, as we can see
in the articles by Kalbﬂeisch and Lawless (1985), Pepe (1991),
Keiding et al. (2001), Putter, Fiocco, and Geskus (2007),
Andersen and Perme (2008), Meira-Machado et al. (2009),
and Ferguson et al. (2012), to name just a few. State occu-
pation and transition probabilities can be computed through
equations like (9) and the results in Web Appendix A. Once
we have the occupation probabilities, the state entry and exit
distributions can be determined. For the sake of space, the
derivations of these probabilities are omitted here for brevity.
5. Bayesian Inference
5.1. Prior and Posterior Distributions
The Bayesian framework requires the speciﬁcation of a prior
distribution for θ. We assume an improper joint prior distri-
bution in which the components of θ are a priori independent
with π(α) ∝ 1 and π(β) ∝ 1. The prior for λ is speciﬁed
as λjlm ∼ gamma(γjlm1, γjlm2), with γjlm1 ≥ 0, γjlm2 ≥ 0, and
π(λjlm|γjlm1, γjlm2) ∝ λγjlm1−1jlm e−γjlm2λjlm , for m = 1, . . . ,Mjl and
all transitions j → l. If γjlm1 = γjlm2 = 0, we get a Jeﬀreys-
type prior for λjlm. In order to maintain a unique marginal
distribution for the gap times, we further assume that τk|η ∼
exponential(η) independently for the paths Pk such that
|Sk| > 2, with density function f (τk|η) = exp(−τk/η)/η, for
τk > 0. Then, after integrating out the frailty w and τk, there
will be only one marginal distribution for the time Tjl even
when the transition j → l may belong to more than one paths.
The prior for η is taken as an inverse gamma distribution with
π(η) ∝ (1/η)γ01+1 exp(−γ02/η), where γ01 > 0 and γ02 > 0 are
hyperparameters chosen to express vague prior distributions.
For the components τk in τ
∗, we assume independent in-
verse gamma distributions with hyperparameters γ03k > 0 and
γ04k > 0. Hence, the prior has expression
π(θ) ∝
{∏
∀ j→l
Mjl∏
m=1
π(λjlm)
}
π(τ∗)π(η), (10)
so that the posterior distribution is given by
π(θ|D) ∝ π(θ)
∫
L(θ|τ,D)
∏
k:|Sk |>2
f (τk|η)dτk. (11)
In the sequel, we study some conditions in order to establish
the propriety of the posterior distribution in (11).
Proposition 2. The likelihood function in (7) satis-
ﬁes L(θ|τ,D) ≤ A0L1(α|D) L2(β, λ|τ,D), where A0 is a
positive constant, L1(α|D) =
∏n
i=1[{
∏Ji−1
j=1 P(δi,sij = si,j+1|zi1,
α(sij))}I(νi=1)+I(νi=0,Ji>1)], and L2(β,λ|τ,D) =
∏n
i=1[{a(τ(Si))
H∗(Si)
∏Ji−1
j=1 hsij ,si,j+1,0(ti,sij , si,j+1) exp(z
′
i2βsij ,si,j+1)}I(νi=1)].
For each parent state j, let P(j) be the set of nP(j) sub-
jects visiting the paths, either complete or incomplete, such
Bayesian Path Speciﬁc Frailty Models 765
that the state j has at least one child, that is, siJi = j.
Deﬁne z
(j)
i1,1 = (z′i1,0′, . . . ,0′)′, . . . , z(j)i1,|Pj |−1 = (0′, . . . ,0′, z′i1)′,
and z
(j)
i1,|Pj | = (0′, . . . ,0′)′, with Pj as in Section 3.1. Further de-
ﬁne the nP(j) × p(|Pj| − 1) matrix z(j)1 =
[
(z
(j)
i1,δij
− z(j)i1,l)′ : l =
δij, l ∈ Pj, and i ∈ P(j)
]
.
Theorem 1. Assume the prior distribution given in (10).
For each parent state j, assume further that the following con-
ditions hold: (i) The matrix z
(j)
1 is of full rank and (ii) There
exists a positive vector e ∈ RnP(j) such that z(j)′1 e = 0. Then,∫
L1(α|D)dα < ∞ if and only if conditions (i) and (ii) hold.
The binary case (|Pj| = 2) studied by Chen and Shao (2001)
is a special case of Theorem 1.
Theorem 2. Assume the prior distribution in (10) with
γjlm1 = γjlm2 = 0. Assume further that for each transition
j → l, there exists at least one complete path P with nP
subjects such that Z2,jl is of full rank, where z2,jl is an
nP × (Mjl + q) matrix with rows (Iijl1, . . . , IijlMjl , z′i2) for i ∈ P.
Then,
∫
L2(β,λ|τ,D)f (τ|η)π(η)π(λ)dβdλdτdη < ∞.
By combining the results in Proposition 2, Theorem 1, and
Theorem 2, we conclude that the posterior distribution in (11)
is proper, that is,
∫
π(θ|D)dθ < ∞.
Roy and Hobert (2007,Appendix A) present a linear
programming problem to check condition (ii) in Theorem 1.
In Theorem 2, we essentially require that at least one event
occurs in each interval (cjl,m−1, cjlm] and the corresponding
covariate matrix is of full rank. The rank conditions in
Theorems 1 and 2 can be checked numerically.
5.2. Bayesian Computations and Model Comparison
The analytical form of the posterior distribution in (11) is not
available. Therefore, we develop an eﬃcient Gibbs sampling
scheme (Robert and Casella, 2004) to draw samples from the
posterior distribution. To this end, we introduce many latent
variables and perform reparameterizations. The details of our
computational development are given in Web Appendix C.
Bayesian computations using the Gibbs sampler were im-
plemented in the FORTRAN language using IMSL subrou-
tines with double precision arithmetic. The convergence of
the Gibbs sampler was checked using several diagnostic tools
discussed in Robert and Casella (2004).
To carry out Bayesian model comparison, we consider
the deviance information criterion (DIC) and the LPML.
We deﬁne the deviance Dev(ϑ) = −2 logL(θ|τ,D), where ϑ =
(θ′, τ ′)′ and L(θ|τ,D) is given in (7). Let ϑ and Dev =
E{Dev(ϑ|D)} denote the posterior means of ϑ and Dev(ϑ),
respectively. According to Spiegelhalter et al. (2002), the
DIC measure is deﬁned as DIC = Dev(ϑ) + 2pθD, where pθD =
Dev − Dev(ϑ) is the eﬀective number of model parame-
ters. The smaller the DIC value, the better the model
ﬁts the data. The posterior means ϑ and Dev can be
estimated by ϑ =∑B
j=1 ϑj/B and Dev =
∑B
j=1 Dev(ϑj)/B,
where ϑ1, . . . ,ϑB are samples from the posterior distribution.
LPML is another useful Bayesian measure of goodness-of-
ﬁt, which is deﬁned based on the conditional predictive or-
dinate (CPO). For the ith observation, we deﬁne CPO as
CPOi =
∫
L(θ|τ,Di)π(ϑ|D(−i))dϑ, where Di is the observed
data for the ith subject, L(θ|τ,Di) is the likelihood for the ith
subject, which is the term inside the product in (7), D(−i) is
the data with Di deleted, and π(ϑ|D(−i)) is the posterior den-
sity of ϑ based on the data D(−i). According to Geisser and
Eddy (1979) and Gelfand and Dey (1994), an approximation
is given by LPML =∑n
i=1 log(ĈPOi), where ĈPOi = [{
∑B
j=1
1/L(θj|τ,Di)}/B]−1. The larger the LPML value, the better
the model ﬁts the data.
6. Simulation Studies
In this section, we conduct a simulation study to assess some
properties of the Bayesian model. For the sake of simplic-
ity and taking into account that the simulations are time
consuming, our study was carried out with the four states
model in Figure S2 (in the Online Supplementary Materials).
In Figure S2, there are K = 3 possible complete paths and
their corresponding states and transitions are given as fol-
lows: P1: 1 → 4, P2: 1 → 2 → 3, and P3: 1 → 2 → 4. There
are two possible incomplete paths as well, namely, IP1: 1 and
IP2: 1 → 2. In the data generation with p = 3, q = 2, and
zi11 = 1, we ﬁrst generate n independent zi13 = zi22 ∼ N(0, 1)
and given zi13, we sample zi12 = zi21 ∼ Bernoulli(1/{1 +
exp(−0.5 − 0.3zi13)}), independent, i = 1, . . . , n, with n =
1000. These values remain ﬁxed throughout the 500 repeti-
tions of the simulations. Sample sizes of about 1000 and even
bigger are not uncommon in multi-state data sets.
For the transition 1 → 4 we adopt the proportional hazards
model. The likelihood function is derived from (7). The prior
distribution in (10) is as in Theorem 2 with γjlm1 = γjlm2 = 0,
for all j, l, and m, whereas γ01 and γ02 are such that the
prior mean and variance of η are (τ2 + τ3)/2 and twice the
mean, respectively. For τ1, the prior is inverse gamma(10, 1).
In the Gibbs sampling algorithm, after discarding the ﬁrst
2000 iterations, the next 3000 iterations were used for pos-
terior inference. In our simulations, the gap times are gen-
erated from an exponential model with cumulative baseline
H0(t) = t, τ2 = 2.0, and τ3 = 1.5. The multinominal proba-
bilities and the gap times are generated from (1) and (3),
whereas the censoring time has a uniform distribution on
(0.3tmax, 1.5tmax), with tmax = 80 chosen to control the cen-
soring rate, leading to 21.6%, 30.4%, 32.0%, 12.3%, and 3.7%
of observations on average in the paths P1, P2, P3, IP1, and
IP2, respectively. The true values of the parameters are given
in Table 1. Note that the ﬁtted model is not the true model,
since the data are generated under a proportional hazards
assumption for the transition 1 → 4.
In the ﬁrst part of our simulation study, we compare the
ﬁts of the Markov, semi-Markov, and frailty models. In the
semi-Markov model, the gap time of the previous transition is
included as a covariate in the model for the hazard function,
as in (3). The hazard functions are given by (4). The likelihood
functions for the Markov and semi-Markov models follow from
the expressions in Hougaard (1999,Sections 3.2 and 4). These
models were ﬁtted using speciﬁc Gibbs sampling algorithms
with the same prior distributions for β and λ as in the frailty
model. Samples from the posterior distributions of β and λ
are drawn applying the same techniques described in Web
Appendix C. For the sake of space, the details are omitted.
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Table 1
Summaries from 500 replications for the frailty model (Par: parameter to be estimated, True: true value of the parameter,
Est: average of the posterior means, SD: average of the posterior standard deviations, RMSE: root mean squared error of the
posterior means, and CP: coverage probability of the 95% HPD interval). (a) Parameter estimates and (b) survival
probability estimates for terminating events.
(a) (b)
True
Par True Est SD RMSE CP t0 P(T3 > t0) Est SD RMSE CP
α121 1.0 1.00 0.12 0.12 0.964
α122 −0.5 −0.51 0.09 0.09 0.932 1 0.338 0.339 0.020 0.019 0.952
α123 0.5 0.51 0.16 0.15 0.954 5 0.240 0.231 0.038 0.039 0.958
α231 0.7 0.71 0.16 0.16 0.938 10 0.190 0.177 0.050 0.053 0.960
α232 1.0 1.02 0.11 0.12 0.938 20 0.145 0.128 0.063 0.066 0.956
α233 −1.0 −1.02 0.19 0.19 0.952 n = 2000 0.136 0.043 0.043 0.946
β121 1.0 1.01 0.08 0.08 0.944 True
β122 −1.5 −1.50 0.15 0.16 0.940 t0 P(T4 > t0) Est SD RMSE CP
β121 −1.5 −1.51 0.08 0.08 0.960 1 0.484 0.480 0.019 0.018 0.948
β142 −0.5 −0.50 0.15 0.14 0.958 5 0.332 0.323 0.031 0.032 0.974
β231 0.3 0.30 0.11 0.11 0.962 10 0.258 0.244 0.044 0.046 0.962
β232 −0.5 −0.50 0.21 0.21 0.942 20 0.189 0.172 0.059 0.062 0.954
β241 −1.5 −1.50 0.11 0.11 0.948 n = 2000 0.181 0.043 0.042 0.962
β242 −1.0 −1.01 0.20 0.21 0.942
τ2 2.0 1.98 0.23 0.22 0.948
τ3 1.5 1.52 0.21 0.20 0.950
λ121 1.0 1.02 0.13 0.13 0.952
λ141 1.0 1.09 0.13 0.15 0.936
λ231 1.0 1.02 0.16 0.16 0.960
λ241 1.0 1.05 0.20 0.21 0.938
For each model used in the generation of the simulated data
sets (true model) in Table S3 (in the Online Supplementary
Materials), we ﬁt the frailty, Markov, and semi-Markov mod-
els. The averages of LPML and DIC over the 500 repetitions
of the simulations, as well as the percentage of data sets in
which the true model was selected (correctness), are shown in
Table S3. When the model with frailties in paths P2 and P3
is the true one, our frailty model (even not the true model),
by far, outperforms the Markov and semi-Markov models. On
the other hand, when the data are generated from the Markov
model, both the Markov and semi-Markov models yield simi-
lar results, so that the correctness of the Markov model, less
than 100%, is not unexpected.
Moreover, we also assess some frequentist properties of the
Bayesian model. The results are shown in Table 1. In Ta-
ble 1a, the biases are almost negligible. There is a good agree-
ment between the averages of the posterior standard deviation
(SD) and the root mean squared error of the posterior means
(RMSE), suggesting that the uncertainty in the estimates is
adequately accounted for. The coverage probabilities of the
95% highest posterior distribution (HPD) intervals diﬀer from
the nominal value by at most 2.8%.
Table 1b shows the survival probabilities for terminating
events, which are computed using the results established in
Web Appendix A. The true probabilities are obtained by
integrating out z1 and z2 with respect to their true joint
distribution. Since our main goal here is to estimate the
survival probabilities, we take just one piece for each tran-
sition with λ121 = 0.5, λ141 = 1.2, λ231 = 0.8, and λ241 = 0.5,
whereas the true values of α, β, and η are those in Table 1a.
When the events are more extreme, the estimators are more
biased. However, the biases are reduced when the sample
size increases to 2000. Furthermore, SD and RMSE decrease
at a rate of about n−1/2. The coverage probabilities of the
95% HPD intervals are in general close to the nominal value
for all events. On the whole, despite the small number of
samples for posterior inference when compared to Section 7,
the results in Table 1 demonstrate a good performance of the
point and interval Bayesian estimators under the scenarios
considered in our study and using the piecewise constant
baseline hazard described in Section 3.2.
7. Analysis of the BMT Data
We carry out a detailed analysis of the BMT data described
in Section 2. The prognostic factors in Table S2 are the co-
variates both for the probabilities in (1) and for the haz-
ard functions in (3). In (10) the hyperparameters were set
at γjlm1 = γjlm2 = 0, for all j, l, and m, γ01 = γ02 = 0.01, and
γ03 = γ04 = 5. When running the Gibbs sampling algorithm,
the ﬁrst 2000 iterations were discarded. Then, we performed
200,000 additional iterations with thinning equal to 20, lead-
ing to 10,000 samples for each parameter. Table S4 (in the
Online Supplementary Materials) shows the values of the com-
parison criteria for frailty models having diﬀerent numbers of
intervals in the transitions. According to the DIC and LPML
values, we select model 6 as our working model, noticing that
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Table 2
Posterior means (posterior standard deviations) of the regression coeﬃcients under model 6 for the BMT data
Multinomial probabilities (α)
Transition
Intercept and
prognostic factor Categories 1→2 1→3 1→5 2→4 2→5 3→4 3→5 4→5
Intercept 1.61 1.77 0.94 −0.70 −1.29 0.84 0.32 −1.60
(0.10) (0.10) (0.11) (0.09) (0.12) (0.09) (0.11) (0.12)
Donor recipient
gender mismatch Yes −0.18 −0.16 0.03 0.37 0.43 0.03 −0.27 −0.49
(0.20) (0.20) (0.22) (0.20) (0.26) (0.21) (0.24) (0.27)
Prophylaxis Yes −0.41∗ −0.39∗ 0.12 −0.53∗ 0.31 −0.14 −0.56∗ −0.05
(0.20) (0.20) (0.22) (0.23) (0.27) (0.21) (0.24) (0.28)
Year of transplant 1990–1994 0.95 0.64 0.39 −0.22 −0.23 1.24∗ 0.83∗ 0.11
(0.22) (0.21) (0.23) (0.24) (0.30) (0.23) (0.23) (0.29)
1995–1998 1.14 0.57 0.49 −0.13 0.09 1.44∗ 0.15 −0.32
(0.24) (0.23) (0.26) (0.24) (0.31) (0.24) (0.27) (0.32)
Age at transplant (20, 40] −0.66∗ −0.51∗ −0.92∗ 0.56∗ −0.27 −0.85∗ −0.31 0.34
(years) (0.25) (0.25) (0.26) (0.22) (0.27) (0.24) (0.26) (0.28)
>40 −0.60∗ −0.64∗ −1.21∗ 0.72∗ −0.21 −1.03∗ −0.67∗ 0.00
(0.29) (0.29) (0.32) (0.25) (0.31) (0.29) (0.33) (0.35)
Hazards (β)
Transition
Prognostic factor Categories 1→2 1→3 1→5 1→6 2→4 2→5 2→6 3→4 3→5 3→6 4→5 4→6
Donor recipient
gender mismatch Yes −0.01 −0.23∗ 0.29 −0.25 −0.43∗ 0.25 0.28 −0.08 −0.22 −0.75∗ 0.70∗ 0.49∗
(0.10) (0.09) (0.37) (0.39) (0.16) (0.30) (0.43) (0.12) (0.37) (0.24) (0.31) (0.18)
Prophylaxis Yes −0.41∗ −0.04 0.62 −0.79∗ −0.12 0.05 −0.04 −0.20 0.53 −0.27 0.13 −0.16
(0.11) (0.09) (0.36) (0.37) (0.21) (0.34) (0.40) (0.13) (0.34) (0.21) (0.31) (0.22)
Year of transplant 1990–1994 −0.06 −0.14 0.49 0.79∗ −0.17 0.13 −0.75 0.05 −0.27 −0.12 −1.03∗ −0.33
(0.12) (0.10) (0.39) (0.38) (0.20) (0.37) (0.41) (0.14) (0.31) (0.22) (0.30) (0.23)
1995–1998 0.11 −0.13 0.34 0.49 −0.05 0.30 −0.83 0.02 −0.38 0.07 −0.68∗ −0.32
(0.12) (0.10) (0.45) (0.44) (0.21) (0.37) (0.46) (0.14) (0.46) (0.26) (0.33) (0.23)
Age at transplant (20, 40] 0.36∗ −0.18 −0.09 −0.10 −0.40 −0.25 0.17 −0.02 0.24 −0.37 0.19 0.82∗
(years) (0.11) (0.09) (0.37) (0.50) (0.20) (0.38) (0.52) (0.12) (0.38) (0.27) (0.34) (0.28)
>40 0.30∗ −0.23∗ −0.02 −0.17 −0.27 −0.10 1.55∗ 0.20 0.60 −0.48 0.86∗ 1.38∗
(0.12) (0.11) (0.52) (0.57) (0.22) (0.36) (0.51) (0.15) (0.46) (0.31) (0.40) (0.29)
For the estimates marked with ∗, the 95% HPD intervals do not contain 0.
model 6i denotes the independent gap time (i.e., no-frailty)
model. For model 6, Figures S3–S6 (in the Online Supple-
mentary Materials) show the trace plots for α34, β15, λ24,
and (τ1, . . . , τ10)
′, respectively, whereas Figure S7 shows the
trace, histogram, ergodic mean, and autocorrelation plots for
η. These plots, as well as the omitted ones, indicate that the
chains have a good mixing and converge. Regarding π(τ1) and
π(τ10), a sensitivity analysis for model 6 with values of γ03 and
γ04 in {1, 2, 5, 10, 50} shows that the best ﬁt is achieved when
γ03 = γ04 = 5.
Next we present some results obtained from the samples of
the posterior distribution. Table 2 shows the posterior means
and standard deviations for the regression coeﬃcients under
model 6. A coeﬃcient is signiﬁcant when its 95% HPD in-
terval does not contain 0. We see, for example, that at a 5%
level, donor recipient gender mismatch is not signiﬁcant for
the probabilities in (1). For the transition 4 → 5, there are no
signiﬁcant eﬀects of the prognostic factors. With respect to
the hazards in (3), for the transitions 1 → 5, 2 → 5, 3 → 4,
and 3 → 5, the eﬀects of the prognostic factors are not signif-
icant.
The point estimate and the HPD interval for the frailty
standard deviation η are 0.151 and (0.048, 0.291), respectively.
The posterior means of τ2, . . . , τ9 in (2) range from 0.016 (P5)
to 0.323 (P3), so that there is some heterogeneity in the frailty
distribution for the paths with more than two states. We also
see that the largest means correspond to the shortest paths
(P3, P8, P2, and P9). For paths P1 and P10, the posterior
means of τ1 and τ10 are 3.92 and 1.61, giving an indication
that the proportional hazards assumption is not tenable.
Figure 2a and b display the diﬀerences in the path probabil-
ities taking the age class ≤20 years at transplant as reference
class and ﬁxing the levels of the remaining prognostic fac-
tors. In some cases, there is a signiﬁcant diﬀerence between
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Figure 2. Diﬀerences in the path probabilities and 95% HPD intervals according to age at transplant class in years under
model 6 (reference class: ≤20, left: (20, 40], and right: >40). (a) Donor–recipient gender mismatch: no, prophylaxis: no, and
year of transplant: 1990–1994, (b) donor–recipient gender mismatch: yes, prophylaxis: yes, and year of transplant: 1985–1989,
and (c) path probabilities and 95% HPD intervals according to age at transplant class in years under model 6 (left: ≤20,
middle: (20, 40], and right: >40).
the path probabilities for the upper age classes with respect
to the reference age class. In Table 2, the posterior means
of the components in α12, α13, and α15 corresponding to the
age classes are negative and the coeﬃcients are signiﬁcant,
so that the results for paths P1 and P10 would be expected.
In Figure 2c, we consider only the age class after integrat-
ing out with respect to the remaining factors, as discussed
in Section 4.3. Paths P1, P3, and P7 stand out as the most
probable paths, with the posterior means of path probabili-
ties (0.23, 0.18, 0.14), (0.20, 0.18, 0.21), and (0.18, 0.14, 0.16),
respectively, for the age classes ≤20, (20, 40], and >40.
In Figure 3a, we see that donor recipient gender mismatch
has a short time decreasing signiﬁcant eﬀect on the relapse
free probability. With respect to the survival probability in
Figure 3b, the behavior is not monotonic and the eﬀect of
gender mismatch is not signiﬁcant.
The eﬀect of age at transplant on the relapse free proba-
bility is not signiﬁcant, as shown in Figure 4a. In Figure 4b,
we see that the survival probability of the youngest patients
at transplant becomes greater than the probability of older
patients for after a few months. The HPD intervals for the
diﬀerences in survival probabilities do not contain 0 after
about 3 years. For example, when the time is set at 6 years,
the posterior means of the diﬀerences for the age classes
(20, 40] and >40 are −0.0498 and −0.0533, with HPD inter-
vals (−0.0850,−0.0125) and (−0.0947,−0.0128), respectively.
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Figure 3. Diﬀerences and 95% HPD intervals (dashed lines) according to donor recipient gender mismatch under model 6
(reference class: no gender mismatch). (a) Relapse free probability and (b) survival probability.
When the time is set at 10 years, the posterior means are
−0.0535 and −0.0613 with HPD intervals (−0.0895,−0.0176)
and (−0.102,−0.0206), respectively.
8. Discussion and Future Directions
When the number of internal states is large and the sample
size is not suﬃciently large, posterior propriety may be an
issue due to the small number of events in certain paths. In
this case, the path diagram is sparse and the conditions in
Theorem 2 may not be satisﬁed. However, under the Bayesian
approach, with a moderately informative prior we can handle
the sparsity of the data. Certainly, a sensitivity analysis on
the speciﬁcation of priors needs to be carried out. On the
other hand, if there are too many paths, the model may not
be clinically useful. By collapsing some transient states, we
can obtain a simpler path diagram.
Although lots of work have been done, there are various
areas for future research. Our proposed model covers the
situations in which the path diagram is unidirectional. The
methodology can be extended to a more general setting such
as the disability model in Figure S1 (in the Online Supple-
mentary Materials) allowing for recovery from the disease.
We emphasize that under our model, the path probabilities
are easily estimated as a by-product of the Gibbs sampler.
Paths with outstanding estimates might be useful to clini-
cians and can be used to classify the patients into diﬀerent risk
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Figure 4. Diﬀerences and 95% HPD intervals (dashed lines) according to age at transplant class in years under model 6
(reference class: ≤20, “•”: (20, 40] and “◦”: >40). (a) Relapse free probability and (b) survival probability.
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groups. The inclusion of time dependent covariates imposes
additional challenges. In our formulation, the conditions in
Section 5.1 require that all complete paths must be observed
in the data. Otherwise, more informative prior distributions
should be elicited from experts or historical data, if available,
can be used to construct a power prior distribution (see, e.g.,
Chen, Ibrahim, and Yiannoutsos, 1999).
Our model assumes equal frailties for the gap times of a
given subject. This can be extended to a correlated frailty
model (Wienke, 2011, Chapter 5) with transition speciﬁc frail-
ties in a given path. A multivariate log-normal distribution for
the vector of frailties w = (wjl : j, l ∈ Sk)′ can replace (2), al-
lowing a more ﬂexible correlation structure for the gap times
in a path. Moreover, the gamma frailty imposes a positive cor-
relation between two gap times in the same path. This can be
relaxed by using a copula model (Wienke, 2011, Chapter 6)
with path speciﬁc parameters.
9. Supplementary Materials
The detailed computation of the survival probabilities for ter-
minating events in Section 4.3 and the required steps for im-
plementing the Gibbs sampling algorithm for posterior infer-
ence in Section 5.2 are presented in Web Appendix A and Web
Appendix C, respectively. The proofs of propositions and the-
orems are given in Web Appendix B. Online Supplementary
Materials include also ﬁgures for the three and four states
models in Sections 4.1 and 6. Figures S3–S7 display plots of
the posterior distribution for some elements. Tables S2 and
S3 pertain to Sections 2 and 6, respectively, whereas Table S4
is discussed in Section 7. Web appendices, tables, and ﬁgures
referenced in the paper are available with this paper at the
Biometrics website on Wiley Online Library
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